Back to Search
WADE ROSENBERG, MD
MD
Surgery Physician
NPI: 1881694404Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
G0029(TX)
Research & Publications (20)
A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
PMID 19243499·J Viral Hepat·2009
8-other
Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells.
PMID 19299698·J Immunol·2009
7-preclinical
Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk individuals: a systematic review.
PMID 19309267·Genet Test Mol Biomarkers·2009
1-meta
Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.
PMID 19406046·Health Technol Assess·2009
1-meta
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.
PMID 18992746·Gastroenterology·2009
8-other
Health outcomes following liver function testing in primary care: a retrospective cohort study.
PMID 19439435·Fam Pract·2009
8-other
Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE).
PMID 19413926·Health Technol Assess·2009
8-other
A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action.
PMID 18341617·Clin Exp Immunol·2008
8-other
A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.
PMID 18310265·J Med Genet·2008
1-meta
Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
PMID 18984472·Clin Liver Dis·2008
6-review
A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations.
PMID 18522976·QJM·2008
8-other
Renal hepatitis C in the absence of detectable serum or hepatic virus.
PMID 18647143·Liver Int·2008
5-case
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.
PMID 18846542·Hepatology·2008
8-other
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.
PMID 18038452·Hepatology·2008
4-observational
Gastroduodenal artery used for arterial reconstruction during the Whipple operation.
PMID 18265638·Hepatogastroenterology·2007
8-other
Evidence based medicine: what it is and what it isn't. 1996.
PMID 17340682·Clin Orthop Relat Res·2007
8-other
Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells.
PMID 17362265·Clin Exp Immunol·2007
4-observational
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).
PMID 17437630·BMC Health Serv Res·2007
8-other
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
PMID 17014573·Aliment Pharmacol Ther·2006
6-review
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
PMID 17047111·Gut·2006
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6560 FANNIN ST, SUITE 1750
HOUSTON, TX 77030 - Phone
- (713) 790-4830
Quick Facts
- NPI
- 1881694404
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile